TARDBP and Alzheimer disease: The clinical presentation of AD can be affected by co-pathologies, such as α-synuclein accumulation, vascular pathology, TAR DNA-binding protein 43 pathology, and non-AD tauopathies, particularly in the aging population, as co-pathologies increase with age.